The Her2 Antibodies Market is witnessing a significant evolution, with a projected market share of $76.37 billion by 2035. This represents a remarkable growth trajectory driven by the escalating demand for targeted cancer therapies. Advanced research methodologies and innovative treatment modalities are reshaping market dynamics. The growing prevalence of HER2-positive breast cancers is...